Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Debiopharm Innovatoin Fund & Taiwania Capital co-lead financing round for Genialis to propel drug development, diagnostics and treatment planning through AI/ML-enabled platform with a biology-first approach BOSTON, LAUSANNE, Switzerland and LJUBLJANA, Slovenia, March 29, 2023 /PRNewswire/…